Novadip Biosciences

Novadip Biosciences is an advanced biopharmaceutical company focused on developing next-generation therapies using adipose-derived stem cells for hard and soft tissue reconstruction. The first proprietary cell therapy of Novadip Biosciences is a fully differentiated, scaffold-free 3D bone structure that provides an innovative treatment for severe bone healing disorders. Their lead product, NVD-001, introduces a new principle of guided tissue regeneration based on adipose tissue-derived stem cells, associated with osteoinductive, osteoconductive, and osteogenic properties, to create 3D natural bone implants with the correct shape and all mechanical properties for the replacement and repair of large bone defects.